Interestingly, a recent study focused on the role of FGF19/FGFR4/KLB signaling pathway in the development of thyroid cancers with upregulation of serum levels of KLB, FGF19, and FGFR4 in patients with thyroid cancer, compared to healthy controls [51]. Here, KLB is linked to thyroid gland carcinoma.